Gene therapy tested on cystic fibrosis; New peptide platform safeguards therapies;

> A new study by the Laboratory for Molecular Virology and Gene Therapy at KU Leuven in Belgium spotlights a gene therapy for cystic fibrosis, which proved effective in mice as well as cell cultures. Release

> Chemists at the University of California, San Diego, have developed a new platform tech for peptides, using a "densely branching polymer" to protect them from the natural hazards that make peptides hard to develop as therapeutics. Release

Suggested Articles

German scientists are targeting a protein-cutting enzyme that many viruses, including the coronavirus COVID-19, need to replicate.

UPenn scientists found blocking the Wnt/beta-catenin pathway in endothelial cells made chemotherapy more effective in mouse models of glioblastoma.

Astellas’ Xospata and Novartis’ Rydapt may help treat lung cancer that has grown resistant to EGFR inhibitors, researchers discovered.